HERPES ZOSTER HOUSE EPIDEMIC IN STEROID-TREATED PATIENTS. A CLINICAL AND VIRAL STUDY.
D001151:Arsenic; D003348:Cortisone / Q000627:therapeutic use*; D003588:Cytopathogenic Effect, Viral; D003907:Dexamethasone; D004358:Drug Therapy; D004813:Epidemiology; D004917:Erythromycin; D005455:Fluorescent Antibody Technique; D005853:Geriatrics; D006562:Herpes Zoster; D014645:Herpesvirus 3, Human; D006801:Humans; D006821:Hyaluronoglucosaminidase; D008712:Methicillin; D009437:Neuralgia; D009500:Neutralization Tests; D010118:Oxytetracycline; D011041:Poisoning; D011239:Prednisolone / Q000627:therapeutic use*; D013148:Spironolactone; D014805:Vitamin B 12
D013148:Spironolactone; D004917:Erythromycin; D003907:Dexamethasone; D011239:Prednisolone; D006821:Hyaluronoglucosaminidase; D001151:Arsenic; D014805:Vitamin B 12; D008712:Methicillin; D003348:Cortisone; D010118:Oxytetracycline
ARSENIC; CORTISONE, THERAPEUTIC; CYTOPATHOGENIC EFFECT, VIRAL; DEXAMETHASONE; DRUG THERAPY; EPIDEMIOLOGY; ERYTHROMYCIN; FLUORESCENT ANTIBODY TECHNIC; GERIATRICS; HERPES ZOSTER; HYALURONIDASE; METHICILLIN; NEURALGIA; NEUTRALIZATION TESTS; OXYTETRACYCLINE; POISONING; PREDNISOLONE, THERAPEUTIC; SPIRONOLACTONE; VARICELLA-ZOSTER VIRUS; VITAMIN B 12